NEWS
Cochlear loses final appeal hope in infringement case
MELBOURNE: Hearing implant maker Cochlear has lost its final chance to appeal the hefty $US268… read more
Mesoblast shares savaged on poor COVID trial results
MELBOURNE: Stem cell biotech Mesoblast has had its share price smashed after the company emerged… read more
12 new senior healthcare executives sought for key roles
MELBOURNE: Twelve senior healthcare, aged and retirement village executive positions remain open. New positions listed… read more
RAM bulks up for float with triple hospital deal
SYDNEY: Real Asset Management (RAM) has reached its target of $500 million of assets under… read more
